These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29769559)

  • 1. Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease.
    Dai W; Long J; Cheng Y; Chen Y; Zhao S
    Sci Rep; 2018 May; 8(1):7726. PubMed ID: 29769559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
    Dai W; Zhang Z; Zhao S
    Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Am J Cardiol; 2021 Aug; 152():34-42. PubMed ID: 34130824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study.
    Zhou BY; Sun D; Wang C; Wu NQ; Guo YL; Zhu CG; Gao Y; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2019 Jul; 28(7):1009-1017. PubMed ID: 31178022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
    Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery Disease.
    Xu N; Jiang L; Xu L; Tian J; Zhang C; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Song L; Yuan J
    Am J Cardiol; 2020 Feb; 125(4):528-533. PubMed ID: 31864520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Prognostic Value of Lipoprotein(a) in Symptomatic Patients With Nonobstructive Coronary Artery Disease.
    Xie H; Chen L; Liu H; Cui Y; Zhang Z; Cui L
    Am J Cardiol; 2017 Apr; 119(7):945-950. PubMed ID: 28139221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease.
    Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Hong LF; Li JJ
    Heart; 2020 Aug; 106(16):1228-1235. PubMed ID: 32381650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study.
    Liu SL; Wu NQ; Guo YL; Zhu CG; Gao Y; Sun J; Xu RX; Liu G; Dong Q; Li JJ
    Postgrad Med J; 2019 Oct; 95(1128):534-540. PubMed ID: 31315919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease.
    Liu HH; Guo YL; Wu NQ; Zhu CG; Gao Y; Qing P; Li S; Zhao X; Zhang Y; Sun D; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 Aug; 263():104-111. PubMed ID: 28623739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.
    Leistner DM; Laguna-Fernandez A; Haghikia A; Abdelwahed YS; Schatz AS; Erbay A; Roehle R; Fonseca AF; Ferber P; Landmesser U
    Eur J Prev Cardiol; 2024 May; 31(7):856-865. PubMed ID: 38348689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) screening in young and middle-aged patients presenting with acute coronary syndrome.
    Jubran A; Zetser A; Zafrir B
    Cardiol J; 2019; 26(5):511-518. PubMed ID: 30234895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.
    Naka KK; Bechlioullis A; Marini A; Sionis D; Vakalis K; Triantis G; Wilkins L; Rogus J; Kornman KS; Witztum JL; Doucette-Stamm L; Michalis LK; Tsimikas S
    J Clin Lipidol; 2018; 12(2):338-347. PubMed ID: 29310992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Lipoprotein(a) has Incremental Prognostic Value in Type 2 Diabetic Patients with Symptomatic Coronary Artery Disease.
    Kwon SW; Kim JY; Sung JM; Yoon YW; Rhee JH; Lee BK; Jung YH; Kim KH; Cha JJ; Park JK; Choi EY; Hong BK; Rim SJ; Kwon HM
    J Atheroscler Thromb; 2015; 22(5):527-34. PubMed ID: 25445892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.